Get started
DEXWireNews

Phio Pharmaceuticals Corp Targets $phio

Long
Phio Pharmaceuticals Corp. (NASDAQ:PHIO)  
DEXWireNews  
NASDAQ:PHIO   Phio Pharmaceuticals Corp.
Trend Analysis Harmonic Patterns Chart Patterns
11
0
trendanalysis harmonicpatterns chartpattern
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our Mobile App >>

Android: dexwirenews.com/APP

Apple: dexwirenews.com/iOS

2) Join our Telegram >> t.me/DEXWireNews

3) Follow @DEXWireNews on Social Media
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.